Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository

Objective:Cross-sectional HIV incidence surveillance, using assays that distinguish ‘recent’ from ‘nonrecent’ infections, has been hampered by inadequate performance and characterization of incidence assays. In this study, the Consortium for the Evaluation and Performance of HIV Incidence Assays presents results of the first independent evaluation of five incidence assays (BED, Limiting Antigen Avidity, Less-sensitive Vitros, Vitros Avidity and BioRad Avidity). Design:A large repository of diverse specimens from HIV-positive patients was established, multiple assays were run on 2500 selected specimens, and data were analyzed to estimate assay characteristics relevant for incidence surveillance. Methods:The mean duration of recent infection (MDRI, average time ‘recent’ while infected for less than some time cut-off T) was estimated from longitudinal data on seroconverters by regression. The false-recent rate (FRR, probability of testing ‘recent’ when infected for longer than T) was explored by measuring the proportions of ‘recent’ results in various subsets of patients. Results:Assays continue to fail to attain the simultaneously large MDRI and small FRR demanded by existing performance guidelines. All assays produce high FRRs amongst virally suppressed patients (>40%), including elite controllers and treated patients. Conclusions:Results from this first independent evaluation provide valuable information about the current performance of assays, and suggest the need for further optimization. Variation of ‘recent’/‘nonrecent’ thresholds and the use of multiple antibody-maturation assays, as well as other biomarkers, can now be explored, using the rich data generated by the Consortium for the Evaluation and Performance of HIV Incidence Assays. Consistently high FRRs amongst those virally suppressed suggest that viral load will be a particularly valuable supplementary marker. Video abstract:http://links.lww.com/QAD/A569

[1]  R. Brookmeyer,et al.  Risk factors and clinical presentation of acute primary HIV infection in India. , 1997, JAMA.

[2]  Susan A. Murphy,et al.  Monographs on statistics and applied probability , 1990 .

[3]  Michael P Busch,et al.  Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection , 2003, AIDS.

[4]  Oliver Laeyendecker,et al.  Estimation of HIV incidence using multiple biomarkers. , 2013, American journal of epidemiology.

[5]  R. Byers,et al.  Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. , 2002, AIDS research and human retroviruses.

[6]  Michael P Busch,et al.  Use of laboratory tests and clinical symptoms for identification of primary HIV infection , 2002, AIDS.

[7]  Debra Hanson,et al.  Lower-Sensitivity and Avidity Modifications of the Vitros Anti-HIV 1+2 Assay for Detection of Recent HIV Infections and Incidence Estimation , 2012, Journal of Clinical Microbiology.

[8]  M. Battegay,et al.  Sexual transmission during the incubation period of primary HIV infection. , 2001, JAMA.

[9]  W Winkelstein,et al.  The San Francisco Men's Health Study: continued decline in HIV seroconversion rates among homosexual/bisexual men. , 1988, American journal of public health.

[10]  Till Bärnighausen,et al.  A New General Biomarker-based Incidence Estimator , 2012, Epidemiology.

[11]  Gonzalo Domingo,et al.  More and Better Information to Tackle HIV Epidemics: Towards Improved HIV Incidence Assays , 2011, PLoS medicine.

[12]  A. Blaxhult,et al.  Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure , 2000, AIDS.

[13]  L. Meyer,et al.  Biomarker-Based HIV Incidence in a Community Sample of Men Who Have Sex with Men in Paris, France , 2012, PloS one.

[14]  Oliver Laeyendecker,et al.  Estimating HIV Incidence in Populations Using Tests for Recent Infection: Issues, Challenges and the Way Forward. , 2010, Journal of HIV AIDS surveillance & epidemiology.

[15]  Tanmoy Bhattacharya,et al.  Modeling sequence evolution in acute HIV-1 infection. , 2009, Journal of theoretical biology.

[16]  A. Agresti,et al.  Approximate is Better than “Exact” for Interval Estimation of Binomial Proportions , 1998 .

[17]  John N. Nkengasong,et al.  Detection of Recent HIV-1 Infection Using a New Limiting-Antigen Avidity Assay: Potential for HIV-1 Incidence Estimates and Avidity Maturation Studies , 2012, PloS one.

[18]  F. Hecht,et al.  The effects of early antiretroviral therapy and its discontinuation on the HIV-specific antibody response. , 2006, AIDS research and human retroviruses.

[19]  R Brookmeyer,et al.  Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. , 1995, American journal of epidemiology.

[20]  T. Schacker,et al.  Clinical and Epidemiologic Features of Primary HIV Infection , 1996, Annals of Internal Medicine.

[21]  Connie Celum,et al.  HIV incidence determination in the United States: a multiassay approach. , 2013, The Journal of infectious diseases.

[22]  S. Owen,et al.  Evaluation of a Multiplex Assay for Estimation of HIV-1 Incidence , 2013, PloS one.

[23]  Susan Little,et al.  Diagnosis of Primary HIV-1 Infection , 2001, Annals of Internal Medicine.

[24]  W. Miller,et al.  Improved detection of acute HIV-1 infection in sub-Saharan Africa: development of a risk score algorithm , 2007, AIDS.

[25]  Jeffrey N. Martin,et al.  Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. , 2008, The Journal of infectious diseases.

[26]  E. Vittinghoff,et al.  Transmitted Drug Resistance in Persons with Acute/Early HIV-1 in San Francisco, 2002-2009 , 2010, PloS one.

[27]  A. Kamali,et al.  Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa. , 2011, AIDS research and human retroviruses.

[28]  Richard D Moore,et al.  Effect of Natural and ARV-Induced Viral Suppression and Viral Breakthrough on Anti-HIV Antibody Proportion and Avidity in Patients with HIV-1 Subtype B Infection , 2013, PloS one.

[29]  D. Richman,et al.  Evaluation of an HIV Nucleic Acid Testing Program With Automated Internet and Voicemail Systems to Deliver Results , 2010, Annals of Internal Medicine.

[30]  Xiping Wei,et al.  Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.

[31]  Devan V Mehrotra,et al.  A Cautionary Note on Exact Unconditional Inference for a Difference between Two Independent Binomial Proportions , 2003, Biometrics.

[32]  Reshma Kassanjee,et al.  Short Communication: Defining optimality of a test for recent infection for HIV incidence surveillance. , 2014, AIDS research and human retroviruses.

[33]  S. Owen,et al.  Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.